Thursday September 19, 2019 16:30

Heathcare Press Release : 14 Sep 2017

Ascensia Diabetes Care Launches Global Innovation Competition to Find Digital Solutions to Help Heathcare—14 Sep 17

Today, during the 53rd Annual Meeting of the European Association for the Study of Diabetes (EASD), Ascensia Diabetes Care announced the launch of the Ascensia Diabetes Challenge, a global innovation competition that is seeking innovative digital

Xultophy(R) Reduces Cardiovascular Risk Factors in People with Type 2 Heathcare—14 Sep 17

In people with type 2 diabetes, Xultophy(R) (insulin degludec/liraglutide) significantly reduced a number of risk factors associated with an increased risk of cardiovascular disease (CVD), compared to basal insulin.[1] According to a new post-hoc